EHA 2022 Conference Coverage


 

Lecture Summary - EHA 2022 Improved OS With 1L Brentuximab Vedotin + Chemo in Stage III/IV Classical Hodgkin Lymphoma: 6-Year Analysis of ECHELON-1

July 26, 2022

0 Comments
Login to view comments. Click here to Login